Cargando…
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
Continuous subcutaneous (s.c.) apomorphine infusion is an effective therapy for Parkinson’s disease (PD), but a limitation is the formation of troublesome s.c. nodules. Various chemically non-identical apomorphine formulations are available. Anecdotal experiences have suggested that shifting from on...
Autores principales: | Hagell, Peter, Höglund, Arja, Hellqvist, Carina, Johansson, Eva-Lena, Löwed, Berit, Sjöström, Anne-Christine, Karlberg, Carina, Lundgren, Margareth, Dizdar, Nil, Johansson, Anders, Willows, Thomas, Rådberg, Johan, Bergquist, Filip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578146/ https://www.ncbi.nlm.nih.gov/pubmed/32613445 http://dx.doi.org/10.1007/s00415-020-10031-1 |
Ejemplares similares
-
Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson’s disease
por: Agbo, Felix, et al.
Publicado: (2021) -
Continuous Subcutaneous Apomorphine Infusion in Advanced Parkinson’s Disease: A Systematic Review
por: Gaire, Suman, et al.
Publicado: (2021) -
Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease
por: Isaacson, Stuart, et al.
Publicado: (2016) -
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
por: Zagnoli, Fabien, et al.
Publicado: (2023) -
Apomorphine
Publicado: (1900)